Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Maraviroc Versus Efavirenz in Combination With Zidovudine/Abacavir on the CD4/CD8 Ratio in Treatment-naïve HIV-infected Individuals

NCT03178084 is registered in ClinicalTrials.gov with Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal as lead sponsor.

NCT NCT03178084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03178084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Maraviroc Versus Efavirenz in Combination With Zidovudine/Abacavir on the CD4/CD8 Ratio in Treatment-naïve HIV-infected Individuals
Lead sponsor
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Phase
Phase 3
Overall status
Completed
Start date
October 15, 2014
Completion date
March 7, 2017
Enrollment
721 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids